Researchers at the Retina Foundation are working diligently to find treatments for patients diagnosed with dry age-related macular degeneration (AMD). Learn more about the clinical trials we are currently enrolling for.

Our researchers are working to develop a drug delivery device for patients with AMD. It is a small Polymer device that slowly releases therapeutic drugs as needed over a period of weeks, months or years as prescribed by your physician.

Age-related macular degeneration can be detected in a routine eye exam. One of the most common early signs of macular degeneration is the presence of drusen — tiny yellow deposits under the retina — or pigment clumping. Research is looking at the role drusen degeneration plays in AMD.

First-in-human trial of a new gene therapy that seeks to restore sight for patients affected with retinitis pigmentosa (Dallas, Texas …